TWD 45.7
(-1.72%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 3.01 TWD | 33.19% |
2022 | 2.26 TWD | 55.86% |
2021 | 1.45 TWD | 806.25% |
2020 | 0.16 TWD | 116.16% |
2019 | -0.99 TWD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.20 TWD | -160.61% |
2024 Q2 | -0.15 TWD | 25.0% |
2023 Q2 | 1.13 TWD | 54.79% |
2023 Q4 | 0.33 TWD | -59.76% |
2023 FY | - TWD | 33.19% |
2023 Q1 | 0.73 TWD | 73.81% |
2023 Q3 | 0.82 TWD | -27.43% |
2022 Q3 | 0.61 TWD | 0.0% |
2022 FY | - TWD | 55.86% |
2022 Q4 | 0.42 TWD | -31.15% |
2021 FY | - TWD | 806.25% |
2020 FY | - TWD | 116.16% |
2019 FY | - TWD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Allied Biotech Corporation | 1.01 TWD | -198.02% |
Easywell Biomedicals, Inc. | -1.25 TWD | 340.8% |
TTY Biopharm Company Limited | 4.54 TWD | 33.7% |
Synmosa Biopharma Corporation | 1.46 TWD | -106.164% |
Orient EuroPharma Co., Ltd. | 1.66 TWD | -81.325% |
Center Laboratories, Inc. | -1.50 TWD | 300.667% |
Tien Liang BioTech Co., Ltd. | 0.39 TWD | -671.795% |
Orient Pharma Co., Ltd. | 0.10 TWD | -2910.0% |
InnoPharmax Inc. | -0.76 TWD | 496.053% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 2.24 TWD | -34.375% |
Excelsior Biopharma Inc. | -1.94 TWD | 255.155% |
DV Biomed Co., Ltd. | 7.89 TWD | 61.85% |
Foresee Pharmaceuticals Co., Ltd. | -8.14 TWD | 136.978% |
Handa Pharmaceuticals, Inc. | 5.41 TWD | 44.362% |
UniPharma Co., Ltd. | -0.61 TWD | 593.443% |
Anxo Pharmaceutical Co., Ltd. | 0.42 TWD | -616.667% |
Alar Pharmaceuticals Inc. | 6.71 TWD | 55.142% |
Winston Medical Supply Co., Ltd. | 8.58 TWD | 64.918% |
Mercury Biopharmaceutical Corporation | -0.11 TWD | 2836.364% |
Bioray Biotech Co., Ltd | -0.38 TWD | 892.105% |
TSH Biopharm Corporation Limited | 1.61 TWD | -86.957% |